Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mastitis in the first year postpartum.

A Vogel1, B L Hutchison, E A Mitchell

  • 1Department of Paediatrics, Auckland University, New Zealand.

Birth (Berkeley, Calif.)
|February 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

ESMO open·2026
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

ESMO podcast on upper GI cancers: highlights in hepatocellular carcinoma and pancreatic cancer from ESMO 2025.

ESMO gastrointestinal oncology·2026
Same author

Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation-Current Evidence and Future Directions. Authors' reply.

Alimentary pharmacology & therapeutics·2026
Same author

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with m<i>IDH1</i> cholangiocarcinoma.

ESMO gastrointestinal oncology·2026
Same journal

Love's Labor Lost and Maternal Mortality, 30 Years Later.

Birth (Berkeley, Calif.)·2026
Same journal

Creative Health and the Impact on Mental Health Support for Women From Minoritized Backgrounds Experiencing Baby Loss: A Scoping Review.

Birth (Berkeley, Calif.)·2026
Same journal

Changing From Midwife to Lead Perinatal Practitioner: Would It Afford the Profession More Authority, Value and Professional Identity Where It Currently Lacks Them?

Birth (Berkeley, Calif.)·2026
Same journal

Respectful Maternity Care and Postpartum Emotional Distress: The Mediating Role of Baby-Friendly Hospital Initiative Practices and Moderation by Support.

Birth (Berkeley, Calif.)·2026
Same journal

The Health, Wellbeing and Health Service Use of Women Attempting or Planning Pregnancy: A Nationwide Cross-Sectional Survey of Australian Women.

Birth (Berkeley, Calif.)·2026
Same journal

Self-Reported Health Problems of Birthing Persons During the First and Second Postpartum Years: Scope and Correlates.

Birth (Berkeley, Calif.)·2026
See all related articles

Lactation mastitis affected 23.7% of mothers, with sore nipples increasing risk. Successful breastfeeding outcomes are generally good, but recurrence factors need further study.

Area of Science:

  • Obstetrics and Gynecology
  • Lactation and Breastfeeding Research
  • Infectious Diseases in Women

Background:

  • Lactation mastitis is a common concern for breastfeeding mothers.
  • Limited data exists on the incidence and contributing factors of mastitis.
  • Understanding mastitis is crucial for supporting maternal and infant health.

Purpose of the Study:

  • To determine the frequency of lactation mastitis.
  • To identify risk factors associated with mastitis development.
  • To evaluate the outcomes of mastitis for breastfeeding mothers.

Main Methods:

  • A cohort study followed 350 mothers and their healthy term infants for one year postpartum.
  • Data analysis included logistic regression to identify risk factors.

Related Experiment Videos

  • Incidence, symptoms, treatments, and recurrence of mastitis were recorded.

    • Main Results:

    • 23.7% of mothers reported mastitis symptoms; 17.4% experienced fever.
    • Sore nipples in the first month increased mastitis risk (RR 2.07).
    • Maternal smoking, water supplementation, and pacifier use were associated with reduced risk.

    Conclusions:

    • Mastitis may indicate an ample milk supply, and continued lactation is generally positive.
    • Mothers with mastitis can be reassured about their ability to breastfeed successfully.
    • Further research is needed on mastitis recurrence and late-lactation episodes.